1. Home
  2. DAWN vs VLRS Comparison

DAWN vs VLRS Comparison

Compare DAWN & VLRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAWN
  • VLRS
  • Stock Information
  • Founded
  • DAWN 2018
  • VLRS 2005
  • Country
  • DAWN United States
  • VLRS Mexico
  • Employees
  • DAWN N/A
  • VLRS N/A
  • Industry
  • DAWN Biotechnology: Pharmaceutical Preparations
  • VLRS Air Freight/Delivery Services
  • Sector
  • DAWN Health Care
  • VLRS Consumer Discretionary
  • Exchange
  • DAWN Nasdaq
  • VLRS Nasdaq
  • Market Cap
  • DAWN 624.8M
  • VLRS 671.0M
  • IPO Year
  • DAWN 2021
  • VLRS N/A
  • Fundamental
  • Price
  • DAWN $7.20
  • VLRS $5.95
  • Analyst Decision
  • DAWN Strong Buy
  • VLRS Buy
  • Analyst Count
  • DAWN 7
  • VLRS 6
  • Target Price
  • DAWN $27.86
  • VLRS $8.18
  • AVG Volume (30 Days)
  • DAWN 2.1M
  • VLRS 635.1K
  • Earning Date
  • DAWN 08-05-2025
  • VLRS 10-21-2025
  • Dividend Yield
  • DAWN N/A
  • VLRS N/A
  • EPS Growth
  • DAWN N/A
  • VLRS N/A
  • EPS
  • DAWN N/A
  • VLRS N/A
  • Revenue
  • DAWN $187,638,000.00
  • VLRS $3,019,191,000.00
  • Revenue This Year
  • DAWN $16.42
  • VLRS N/A
  • Revenue Next Year
  • DAWN $47.52
  • VLRS $12.17
  • P/E Ratio
  • DAWN N/A
  • VLRS N/A
  • Revenue Growth
  • DAWN 2190.50
  • VLRS N/A
  • 52 Week Low
  • DAWN $5.64
  • VLRS $3.49
  • 52 Week High
  • DAWN $16.76
  • VLRS $9.00
  • Technical
  • Relative Strength Index (RSI)
  • DAWN 62.39
  • VLRS 59.96
  • Support Level
  • DAWN $6.71
  • VLRS $5.77
  • Resistance Level
  • DAWN $7.12
  • VLRS $6.17
  • Average True Range (ATR)
  • DAWN 0.32
  • VLRS 0.20
  • MACD
  • DAWN 0.10
  • VLRS -0.02
  • Stochastic Oscillator
  • DAWN 85.05
  • VLRS 66.91

About DAWN Day One Biopharmaceuticals Inc.

Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.

About VLRS Controladora Vuela Compania de Aviacion S.A.B. de C.V.

Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).

Share on Social Networks: